Katharina Kiss
Latest contributions
Tricuspid regurgitation: a new prospect in the management of patients with TR
15 Dec 2022 – From GulfPCR-GIM 2022
Thanks to this GulfPCR-GIM 2022 session, get to understand how the TricValve can help in the management of patients with functional TR, know more about the TricValve Bicaval Valves system, and gain insight into the early adoption experience in the Middle East.
Treatment of severe tricuspid regurgitation - Session with LIVE case
07 Oct 2022 – From AICT-AsiaPCR 2022
Watch the LIVE case management of an 84-year-old male patient, diabetic, hypertensive, with previous PCI on LAD and ICD, permanent AF, and exertional dyspnea for 6 months and learn more about severe tricuspid regurgitation pathology and treatment.
Pushing boundaries in tricuspid therapy - The TricValve solution
22 Dec 2021 – From GulfPCR-GIM 2021
In this session, learn about the TricValve system in the treatment of severe TR and right heart disease, obtain insight from the experts with case scenarios, and understand how the TricValve Transcatheter Bicavel system can help patients with severe TR.
Pushing boundaries in tricuspid therapy - the TricValve solution
08 Oct 2021 – From AICT-AsiaPCR 2021
Discover in this session a new strategy for the treatment of tricuspid regurgitation that can be an excellent alternative option to conventional treatment by studying it in a real situation, on a concrete case.
New horizons in tricuspid therapy, the TricValve solution
19 May 2021 – From EuroPCR 2021
Watch this session presented by Michael Haude, Christoph Naber, Mohamed Abdel-Wahab, Mohd Ghazi Azmee, Yahaya Shaiful Azmi, Katharina Kiss and Ignacio Amat Santos in order to learn about the TricValve system's approach to tricuspid regurgitation and right heart disease, to understand how this new generation of tricuspid valve system may...
New horizons in tricuspid therapy – The tricvalve solution
13 Dec 2020 – From AICT-AsiaPCR 2020
In this session, you will get an overview of the TricValve system’s approach to tricuspid regurgitation and right heart disease, the TricValve’s preliminary data and the ongoing clinical trials, followed by a case demonstration.
This session was originally presented during AICT-AsiaPCR 2020.
